In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 240 for your search:
Cancer Type/Condition:  Endometrial cancer
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: 03/2007, NCT00719017

2.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: gungorduk14, NCT01835119

3.

Phase: Phase IV
Type: Diagnostic
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: P110903, NCT01946672

4.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: GYNEOCC2, NCT01953107

5.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: Speed, NCT02026687

6.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: GOA-NVM1, NCT01432015

7.

Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: GUM-ET/OV, NCT01389986

8.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: GOG-0286B, NCI-2013-02284, U10CA180868, U10CA027469, NCT02065687

9.

Phase: Phase III
Type: Supportive care, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-002948-28, KKS-73-05, NCT00444093

10.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: SARC-GYN1, NCT00162721

11.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 0014-08-RMC, NCT00726635

12.

Phase: Phase III
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000629591, GOG-0249, NCT00807768

13.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: TOTEM, NCT00916708

14.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 76
Sponsor: Other
Protocol IDs: PIP2, CSET 1443, NCT00949039

15.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 40 and over
Sponsor: Other
Protocol IDs: 200917341, CFEM 345AUS63, NCT00997373

16.

Phase: Phase III
Type: Health services research, Supportive care
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: CDR0000667367, RMH-CCR3086, EUDRACT-2008-002152-26, EU-21010, MREC-08/H0903/40, NCT01087268

17.

Phase: Phase III
Type: Treatment
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: ENGOT-EN2-DGCG/EORTC55102, 2010-023081-52, NCT01244789

18.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: RC08/118, NCT01356329

19.

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: TACH-01, NCT01470677

20.

Phase: Phase III
Type: Treatment
Status: Active
Age: 70 and over
Sponsor: Other
Protocol IDs: TOMOGYN - 1105, 2011-A01543-38, NCT01641497

21.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 1203, CDR0000738944, NCI-2012-02001, NCT01672892

22.

Phase: Phase III
Type: Behavioral study, Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 50 to 60
Sponsor: NCI, Other
Protocol IDs: 2011-0739, 5P50-CA098258, NCI-2013-00834, NCT01697566

23.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: AEZS -108-050, NCT01767155

24.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 55
Sponsor: Other
Protocol IDs: KNC13-005, NCT01805115

25.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 2012-GYN/EC-01, NCT01820858
1     
New Search